Revolutionizing Intervertebral Disc Regeneration: Advances and Future Directions in Three-Dimensional Bioprinting of Hydrogel Scaffolds
Xiaobo Zhang,Xidan Gao,Xuefang Zhang,Xin Yao,Xin Kang
DOI: https://doi.org/10.2147/ijn.s469302
IF: 7.033
2024-10-22
International Journal of Nanomedicine
Abstract:Xiaobo Zhang, 1, &ast Xidan Gao, 1, &ast Xuefang Zhang, 1 Xin Yao, 1 Xin Kang 2 1 Department of Spine Surgery, Honghui Hospital, Xi'an Jiaotong University, Xi'An, Shaanxi, P.R. China; 2 Department of Sports Medicine, Honghui Hospital, Xi'an Jiao Tong University, Xi'An, Shaanxi, P.R. China &astThese authors contributed equally to this work Correspondence: Xin Kang, Email Hydrogels are multifunctional platforms. Through reasonable structure and function design, they use material engineering to adjust their physical and chemical properties, such as pore size, microstructure, degradability, stimulus-response characteristics, etc. and have a variety of biomedical applications. Hydrogel three-dimensional (3D) printing has emerged as a promising technique for the precise deposition of cell-laden biomaterials, enabling the fabrication of intricate 3D structures such as artificial vertebrae and intervertebral discs (IVDs). Despite being in the early stages, 3D printing techniques have shown great potential in the field of regenerative medicine for the fabrication of various transplantable tissues within the human body. Currently, the utilization of engineered hydrogels as carriers or scaffolds for treating intervertebral disc degeneration (IVDD) presents numerous challenges. However, it remains an indispensable multifunctional manufacturing technology that is imperative in addressing the escalating issue of IVDD. Moreover, it holds the potential to serve as a micron-scale platform for a diverse range of applications. This review primarily concentrates on emerging treatment strategies for IVDD, providing an in-depth analysis of their merits and drawbacks, as well as the challenges that need to be addressed. Furthermore, it extensively explores the biological properties of hydrogels and various nanoscale biomaterial inks, compares different prevalent manufacturing processes utilized in 3D printing, and thoroughly examines the potential clinical applications and prospects of integrating 3D printing technology with hydrogels. Keywords: intervertebral disc degeneration, 3D bioprinting, hydrogel, novel therapy, challenges Lower back pain is a prevalent condition that impacts approximately 80% of the global population. Intervertebral disc (IVD) degeneration (IVDD) is recognized as the most common cause of lower back pain. Over the years, the incidence of IVDD has significantly risen, particularly with advancing age, leading to a substantial increase in disability rates. Consequently, IVDD poses a considerable economic burden on society. 1,2 IVDD is a natural consequence of the aging process, characterized by a gradual decline in IVD cell viability, dehydration of the extracellular matrix (ECM), and structural abnormalities as the disease advances. The etiology of IVDD is multifactorial and encompasses various factors, such as mechanical trauma, genetic predisposition, sedentary behavior lifestyle, and certain metabolic disorders, but the exact pathogenesis is unknown. Despite decades of persistent efforts by scholars, clinical treatment is still focused on alleviating patients' pain and reducing the incidence of disability, including physiotherapy, closed therapy, and surgery, 3,4 which not only fail to cure the disease at the etiological level but also may lead to complications associated with drugs and surgery. Therefore, it is necessary to develop various novel therapies to meet the goals of tissue regeneration and targeted minimally invasive treatment of diseases. Recently, many novel therapies for IVDD have been developed, including stem cell regenerative therapies, gene-targeted therapies, and regenerative alternative therapies combined with tissue-engineered hydrogels, which cover the current mainstream of novel therapies in IVDD, all of which have various advantages and disadvantages. Significant advancements in medical technology have paved the way for gene-targeted therapy in treating IVDD. This breakthrough represents a promising and thrilling opportunity for IVDD. 5 It is achieved at the genetic level by foreign gene expression of key products such as ECM or inhibition of disease-causing gene expression to delay disease progression, and commonly used vectors include viral vectors, nonviral vectors or gene editing to transport specific bioactive substances. Viral vectors can efficiently replicate and proliferate in cells, and the technology is now mature, mainly including retroviruses, lentiviruses, adenoviruses, and baculoviruses, with certain safety concerns. 6,7 Nearly all nonviral vectors have high safety but low transfection efficiency, including inorganic nanoparticles, natural polymeric nanoparticles, and RNA interference. 8 DNA nuclease -Abstract Truncated-
pharmacology & pharmacy,nanoscience & nanotechnology